Dr. Yi Luo, PhDSenior Director of New Drug Discovery at BiotheusSpeaker
Profile
Dr. Luo Yi has over ten years of biomedical research experience in the UK, US and Canada. He has published in top journals such as Nature Communications, Current Biology, and Small. In 2019, he joined Biotheus Inc. and was recognized as a high-level talent in Zhuhai City, China. At Biotheus Inc., Dr. Luo has led early-stage oncology program development, overseeing multiple multifunctional antibody projects, four of which are in clinical research, including one entering Phase III pivotal studies. He also directed the early discovery of a bispecific antibody program that secured a significant licensing agreement with a multinational pharmaceutical company.